Background illustration for clinical trials search

Paid Clinical Trials Oakland

Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,
Location: San Francisco CA, Los Angeles CA, Torrance CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase3, Recruiting

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: San Francisco CA, West Valley City UT, Aurora CO,
Sponsor: TRIANA Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07491497

Phase1, Phase2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase1, Phase2, Recruiting

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

for
Symptomatic Genetic Dilated Cardiomyopathy
Location: San Francisco CA, Los Angeles CA, San Diego CA,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07210723

Phase2, Phase3, Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

for
Castration-Resistant Prostatic Cancer, Metastasis
Location: San Francisco CA, Los Angeles CA, Orange CA, Seattle WA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06863272

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

for
Buccal Mucosa Squamous Cell Carcinoma,
Location: San Francisco CA, Palo Alto CA, San Jose CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04333537

Phase2, Phase3, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: San Francisco CA, Vallejo CA, Sacramento CA,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase3, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: San Francisco CA, Sacramento CA, Burbank CA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: San Francisco CA, Boise ID, Scottsdale AZ, Tacoma WA,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase3, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: San Francisco CA, Seattle WA, Springdale AR, Brampton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase2, Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for
Renal Cell Carcinoma
Location: San Francisco CA, Nashville TN, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07049926

Phase1, Phase2, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: San Francisco CA, Palo Alto CA, Elk Grove CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Probiotic Administration for Adolescent Depression

for
Depression
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 15 - 24

Code: NCT06898788

Early_phase1, Recruiting

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: San Francisco CA, Seattle WA, Aurora CO, Fort Worth TX,
Sponsor: Jubilant DraxImage Inc.

Sex: All

Age: 1+

Code: NCT03561259

Phase2, Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for
Dravet Syndrome
Location: San Francisco CA, Orange CA, Salt Lake City UT,
Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase3, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for
Metastatic Renal Cell Carcinoma,
Location: San Francisco CA, Burlingame CA, San Mateo CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: San Francisco CA, Redding CA, Bakersfield CA,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

for
Metastatic Melanoma
Location: San Francisco CA, Houston TX
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT04633902

Phase2, Recruiting

NEO100 and High-Grade Meningioma

for
Residual, Progressive or Recurrent Grade II or III Meningioma
Location: San Francisco CA, Santa Monica CA, Los Angeles CA,
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 12+

Code: NCT05023018

Phase2, Recruiting

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

for
Metastatic Melanoma
Location: San Francisco CA
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT03925350

Phase2, Recruiting